Juxtapid

judgement fine regulatory hammer

Pharma

Judge orders Aegerion to pay patients for Juxtapid missteps

Aegerion admitted in court that it touted its cholesterol med Juxtapid for patients with a disease it wasn't approved to treat.

Tracy Staton Jan 31, 2018 8:50am

young

Judge rejects Aegerion's $36M Juxtapid settlement with DOJ

Nov 21, 2017 11:00am

court

Aegerion risked patient safety with Juxtapid marketing, feds say

Sep 25, 2017 12:13pm

Aegerion

Cash-strapped Aegerion scouts for deals to recover from financial hits

May 19, 2016 10:19am